Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Magnetically Controlled Targeted Micro-carrier Systems.

P. Gupta, C. Hung
Published 1989 · Computer Science, Medicine, Biology

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Magnetically controlled targeted drug delivery systems are aimed at concentrating drugs at a defined target site, with the aid of a magnetic field. This technique has been developed specifically for directing drugs away from the reticuloendothelial system (RES). Literature on this topic suggests that these delivery systems are capable of altering the distribution of chemotherapeutic agents in the body. Hence these delivery devices offer the possibility of improving the therapeutic efficacy of the associated drugs. This paper reviews the work done to date towards the development and evaluation of biodegradable and non-biodegradable magnetic targeted drug delivery systems and outlines their future prospects and limitations in cancer chemotherapy.
This paper references
10.1063/1.325219
Magnetic guidance of drug‐carrying microspheres
A. Senyei (1978)
10.1016/0026-2862(84)90065-7
Magnetic targeting of microspheres in blood flow.
C. Driscoll (1984)
10.1126/SCIENCE.181.4101.735
America burning: congress eyes a national fire program.
C. Holden (1973)
10.1248/CPB.34.4244
Effects of dose and vesicle size on the pharmacokinetics of liposomes.
Y. Sato (1986)
10.1016/0163-7258(84)90035-4
Liposomes as drug carriers in cancer chemotherapy.
J. Weinstein (1984)
10.1002/JPS.2600680124
Magnetic microspheres: synthesis of a novel parenteral drug carrier.
K. Widder (1979)
10.1148/127.2.345
Transcatheter embolization for lower gastrointestinal bleeding.
J. Bookstein (1978)
10.1016/0378-5173(87)90044-5
The effects of polyalkylcyanoacrylate nanoparticles on human normal and malignant mesenchymal cells in vitro
E. Gipps (1987)
10.1126/SCIENCE.910155
Liposome accumulation in regions of experimental myocardial infarction.
V. Caride (1977)
10.1016/0378-5173(84)90017-6
Therapeutic possibilities of drugs encapsulated in erythrocytes
D. Lewis (1984)
10.1159/000225763
Comparative study on the cytostatic effects and the tissue distribution of 5-fluorouracil in a free form and bound to polybutylcyanoacrylate nanoparticles in sarcoma 180-bearing mice.
J. Kreuter (1983)
10.1038/262500a0
Temporary intestinal hypoxia induced by degradable microspheres
K. Arfors (1976)
10.1248/BPB1978.4.624
Biomedical applications of magnetic fluids II. 1) preparation and magnetic guidance of magnetic albumin microsphere for site specific drug delivery in vivo.
Y. Morimoto (1981)
10.1007/BFB0034499
Electrical breakdown, electropermeabilization and electrofusion.
U. Zimmermann (1986)
10.1248/CPB.30.3024
Dispersion State of Protein-stabilized Magnetic Emulsions
Y. Morimoto (1982)
10.1002/1097-0142(19800701)46:1<14::AID-CNCR2820460103>3.0.CO;2-N
Sustained‐release properties of microencapsulated mitomycin C with ethylcellulose infused into the renal artery of the dog
T. Kato (1980)
10.1200/JCO.1984.2.5.498
Pharmacologic rationale for regional drug delivery.
J. Collins (1984)
10.3109/02841867809127921
Radiation response modified by degradable starch microspheres. Experiments on the rat's foot.
J. O. Forsberg (1978)
10.1080/15368378409035972
Analysis of an Intensive Magnetic Field on Blood Flow
I. I. Chen (1984)
10.1016/0163-7258(83)90033-5
Magnetic microspheres: a vehicle for selective targeting of drugs.
K. Widder (1983)
10.1097/00004424-197911000-00003
Embolization of the spleen for treatment of splenomegaly and hypersplenism in patients with portal hypertension.
T. Owman (1979)
10.1016/0006-2952(86)90140-1
Drug targeting to the lungs.
D. Ranney (1986)
10.1016/0277-5379(83)90408-X
Selective targeting of magnetic albumin microspheres containing low-dose doxorubicin: total remission in Yoshida sarcoma-bearing rats.
K. Widder (1983)
10.1200/JCO.1983.1.1.24
Constant infusion schedule for adriamycin: a phase I-II clinical trial of a 30-day schedule by ambulatory pump delivery system.
J. Lokich (1983)
10.1016/0163-7258(83)90010-4
Delivery of liposome-encapsulated drugs to macrophages.
C. Alving (1983)
10.1007/BF02798624
Magnetic microspheres for targeting of drugs
U. Schröder (1982)
10.1016/0014-5793(79)80940-0
Preparation and application of magnetic polymers for targeting of drugs
K. Mosbach (1979)
Penicillin in surgery.
A. Fleming (1947)
10.1002/1097-0142(19820815)50:4<631::AID-CNCR2820500403>3.0.CO;2-M
Improved regional selectivity of hepatic arterial bcnu with degradable microspheres
S. Dakhil (1982)
10.1016/0026-2862(86)90018-X
Microvascular permeability of normal and neoplastic tissues.
L. E. Gerlowski (1986)
10.1016/S0140-6736(79)91540-X
MICROENCAPSULATED MITOMYCIN-C THERAPY IN RENAL-CELL CARCINOMA
T. Katō (1979)
10.1248/CPB.31.279
Magnetic guidance of Ferro-colloid-entrapped emulsion for site-specific drug delivery.
Y. Morimoto (1983)
10.1248/CPB.34.4253
Feasibility of magnetic liposomes as a targeting device for drugs.
H. Kiwada (1986)
10.1097/00000658-197803000-00022
Comparison of Regional Versus Systemic Chemotherapy with Adriamycin
M. Didolkar (1978)
10.1089/CDD.1986.3.1
Pharmacologic studies of intra-hepatic artery chemotherapy with degradable starch microspheres.
C. Pfeifle (1986)
10.1159/000225991
Synergic effect of cisplatin, Adriamycin, and cyclophosphamide combination chemotherapy and radiotherapy in non-small cell lung cancer.
S. Yoneda (1985)
10.1016/0378-5173(86)90048-7
Albumin microspheres. II. Effect of stabilization temperature on the release of adriamycin
P. Gupta (1986)
10.1111/j.1749-6632.1960.tb20004.x
REACTION PATTERNS OF THE RETICULOENDOTHELIAL SYSTEM UNDER STIMULATION *
R. Baillif (1960)
Uptake enhancement of platinum in the dog kidney by microencapsulation of cisplatin and local injection.
B. Hecquet (1986)
10.3109/02652048409049364
Toxicity and association of polycyanoacrylate nanoparticles with hepatocytes.
J. Kreuter (1984)
10.1148/RADIOLOGY.140.2.7196055
Transcatheter embolization of pelvic vessels for control of intractable hemorrhage.
E. Lang (1981)
10.1002/1097-0142(19800301)45:5<866::AID-CNCR2820450507>3.0.CO;2-3
Intraarterial infusion chemotherapy for hepatic carcinoma using a totally implantable infusion pump
H. Buchwald (1980)
10.1002/JPS.2600710124
Liposome disposition in vivo II: Dose dependency.
M. Bosworth (1982)
10.1001/ARCHINTE.1970.00310120093014
Physiology and physiopathology of the reticuloendothelial system.
T. Saba (1970)
10.1016/0277-5379(83)90409-1
Selective targeting of magnetic albumin microspheres to the Yoshida sarcoma: ultrastructural evaluation of microsphere disposition.
K. Widder (1983)
10.1111/j.2042-7158.1983.tb04269.x
New magnetic drug carrier
A. Ibrahim (1983)
10.1002/JPS.2600700412
In vivo kinetics of magnetically targeted low-dose doxorubicin.
A. Senyei (1981)
10.1016/0378-5173(88)90072-5
Albumin microspheres. III. Synthesis and characterization of microspheres containing adriamycin and magnetite
P. Gupta (1988)
Effect of a magnetic field on blood flow
Vardanian Va (1973)
10.1126/SCIENCE.3966151
Targeted modulation of acute inflammation.
D. Ranney (1985)
10.1148/RADIOLOGY.147.1.6828710
Transcatheter vessel occlusion: angiographic results versus clinical success.
L. Fel'dman (1983)
10.1002/1097-0142(19810801)48:3<674::AID-CNCR2820480303>3.0.CO;2-E
Arterial chemoembolization with mitomycin C microcapsules in the treatment of primary or secondary carcinoma of the kidney, liver, bone and intrapelvic organs
T. Kato (1981)
Adriamycin and soft tissue injury.
Broadbent Nr (1985)
10.1109/TBME.1980.326598
An Estimate of the Steady Magnetic Field Strength Required to Influence Nerve Conduction
J. Wikswo (1980)
10.1007/BF00253838
Effects of an inhomogeneous magnetic field on flowing erythrocytes
M. Okazaki (1987)
10.1016/0142-9612(83)90070-4
Use of magnetic emulsion as a novel drug carrier for chemotherapeutic agents.
M. Akimoto (1983)
10.1016/0142-9612(82)90009-6
Biomedical applications of magnetic fluids. III. Antitumour effect of magnetic albumin microsphere-entrapped adriamycin on lung metastasis of AH 7974 in rats.
K. Sugibayashi (1982)
10.1111/j.2042-7158.1984.tb02998.x
The role of disintegrants in hard‐gelatin capsules
J. E. Botzolakis (1984)
10.1248/BPB1978.3.264
Biomedical applications of magnetic fluids. i. Magnetic guidance of ferro-colloid-entrapped albumin microsphere for site specific drug delivery in vivo.
Y. Morimoto (1980)
10.1111/j.2042-7158.1986.tb03391.x
The influence of degradable starch microspheres on liver uptake of 5‐fluorouracil after hepatic artery injection in the rat
H. Teder (1986)
10.1038/265407a0
Targeting of drugs
G. Gregoriadis (1977)
10.1016/S0006-291X(75)80433-5
The effect of particle size and charge on the clearance rates of liposomes and liposome encapsulated drugs.
R. Juliano (1975)
10.1001/JAMA.1981.03310360015014
Arterial chemoembolization with microencapsulated anticancer drug. An approach to selective cancer chemotherapy with sustained effects.
T. Kato (1981)
10.3109/00365598109179592
Kidney radioprotection by temporary hypoxia. Experiments with degradable microspheres.
J. O. Forsberg (1981)
10.1002/1097-0142(19800501)45:9<2231::AID-CNCR2820450902>3.0.CO;2-3
Distribution of adriamycin in cancer patients. Tissue uptakes, plasma concentration after IV and hepatic IA administration
Y. Lee (1980)



This paper is referenced by
RECENT ADVANCES IN MICROSPHERES MANUFACTURING TECHN OLOGY
K. P. Meena (2011)
10.1016/0378-5173(90)90064-B
Albumin microspheres. V, Evaluation of parameters controlling the efficacy of magnetic microspheres in the targeted delivery of adriamycin in rats
P. Gupta (1990)
10.1002/pmic.200900377
Concanavalin A‐immobilized magnetic nanoparticles for selective enrichment of glycoproteins and application to glycoproteomics in hepatocelluar carcinoma cell line
Jia Tang (2010)
10.1007/S11705-007-0019-3
Preparation and application of magnetic microsphere carriers
Zhang Bo (2007)
10.1002/CJOC.201190127
Determination of Hydrocortisone in Cosmetics by CdSe/CdS Quantum Dots‐Based Fluoroimmunoassay Using Magnetic Fe3O4/Au Nanoparticles as Solid Carriers
Xiuling Wang (2011)
10.2174/2212711906666190723142057
Smart and Intelligent Stimuli Responsive Materials: An Innovative Step in Drug Delivery System
Arijit Guha (2020)
10.7324/JAPS.2013.31004
Magnetic and compartmental targeting of azathioprine using gelatin microspheres: formulation, physicochemical characterization and in vitro release studies
P. Arunkumar (2013)
10.1016/0969-8051(94)00124-3
Effective targeting of magnetic radioactive 90Y-microspheres to tumor cells by an externally applied magnetic field. Preliminary in vitro and in vivo results.
U. Häfeli (1995)
10.1016/S1672-2515(07)60112-2
Preparation and characterization of superparamagnetic functional polymeric microparticles
Xianqiao Liu (2003)
10.1201/9780203912843-1
Biomedical Application for Magnetic Latexes
A. Elaissari (2003)
10.1016/J.JMMM.2007.09.009
Structural, electrical and magnetic properties of Zr-Mg cobalt ferrite
M. Iqbal (2008)
10.1016/J.BIOMATERIALS.2003.09.095
Lactoferrin and ceruloplasmin derivatized superparamagnetic iron oxide nanoparticles for targeting cell surface receptors.
A. Gupta (2004)
Synthesis and Characterization of Biopolymer capped Zinc ferrite nanoparticles by a thermal treatment method
D. O. Okoroh (2018)
10.1007/978-1-4757-6482-6_38
Magnetically Targeted Microspheres for Intracavitary and Intraspinal Y-90 Radiotherapy
U. Häfeli (1997)
10.4028/www.scientific.net/SSP.232.111
Magnetic Iron Oxide Nanoparticles as Contrast Agents: Hydrothermal Synthesis, Characterization and Properties
Tokeer Ahmad (2015)
10.2217/nnm.11.143
Magnetic targeting strategies in gene delivery.
E. Delyagina (2011)
10.1016/J.BIOMATERIALS.2004.10.012
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications.
A. Gupta (2005)
10.1023/B:BMMD.0000013363.77466.63
Self-Assembled Coatings on Individual Monodisperse Magnetite Nanoparticles for Efficient Intracellular Uptake
Y. Zhang (2004)
10.1016/J.SEPPUR.2006.06.021
Thermosensitive polymer coated nanomagnetic particles for separation of bio-molecules
N. Shamim (2007)
10.1002/0471238961.0418210717210104.A01.PUB2
Drug Delivery Systems
J. Kost (2004)
10.1016/J.MSEC.2006.09.008
High throughput human DNA purification with aminosilanes tailored silica-coated magnetic nanoparticles
Moo Eon Park (2007)
10.1533/9780857096449.2.131
6 – Calcium phosphate-coated magnetic nanoparticles for treating bone diseases
R. Pareta (2012)
10.3109/02652049009028426
Targeted delivery of low dose doxorubicin hydrochloride administered via magnetic albumin microspheres in rats.
P. Gupta (1990)
10.1039/B711870H
Surface protected and modified iron based core-shell nanoparticles for biological applications
Kanchana Somaskandan (2008)
10.1016/J.MSEB.2010.02.025
Shape-controlled synthesis and their magnetic properties of hexapod-like, flake-like and chain-like carbon-encapsulated Fe3O4 core/shell composites
Junhao Zhang (2010)
10.1016/J.SSC.2009.07.018
Dynamic magnetic behaviour and Mössbauer effect measurements of magnetite nanoparticles prepared by a new technique in the co-precipitation method
A. Bandhu (2009)
10.1046/J.1525-1594.1999.06278.X
Biocompatible magnetic polymer carriers for in vivo radionuclide delivery.
W. Schuett (1999)
10.1080/10611860802046224
Targeted delivery of diclofenac sodium via gelatin magnetic microspheres formulated for intra-arterial administration
M. Saravanan (2008)
10.1021/mp900018v
Magnetic nanoparticle drug carriers and their study by quadrupole magnetic field-flow fractionation.
P. Williams (2009)
10.1016/0024-3205(90)90002-9
Comparative disposition of adriamycin delivered via magnetic albumin microspheres in presence and absence of magnetic field in rats.
P. Gupta (1990)
10.1088/0964-1726/15/2/N04
Design and hierarchical synthesis of branched heteromicrostructures
T. Zhang (2006)
10.1134/S1995078013040034
Synthesis of magnetite hydrosols and assessment of their impact on living systems at the cellular and tissue levels using MRI and morphological investigation
S. V. German (2013)
See more
Semantic Scholar Logo Some data provided by SemanticScholar